'Like a Slasher Movie' as Major ASX Stock Crashes

'Like a slasher movie' as major ASX stock crashes

Major healthcare stock Cochlear crashed yesterday. Buyers have not moved in today. Follow the day's events and insights from our business reporters on the ABC News live markets blog.

Aussie hearing implant pioneer shares smashed to decade-low

Cochlear was sold off after dramatically downgrading its full-year earnings guidance for the second time in just over two months, with the Trump administration’s raid on Medicaid funding playing a huge role.

Cochlear profit downgrade ‘shocked the market’, shares at 10-year low

The hearing implant maker’s share price cratered to the lowest level since April 2016 after it warned that softer global sales would hit its bottom line.

Cochlear’s Shock Downgrade Raises Concerns

Cochlear's shock downgrade has challenged the long-held assumption the company is immune to economic cycles

Cochlear Share Price Crashes 39% to $101.60 After Dismal HY26 Results and Guidance Cut

SYDNEY — Cochlear Limited shares plunged as much as 41% on Wednesday, trading as low as $101.60 after the world's leading cochlear implant maker reported disappointing first-half 2026 results, lowered full-year profit guidance and highlighted slower-than-expected adoption of its new Nucleus Nexa system.

ASX 200 Healthcare Stock Under Pressure: Cochlear Faces Sharp Earnings Reset

Cochlear Ltd cuts FY26 guidance sharply, impacting ASX healthcare stocks outlook and valuation dynamics.